Naltrexone Completed Phase 4 Trials for Attention Deficit Disorder With Hyperactivity (ADHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01873729An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.